Insider Selling: Microbix Biosystems Inc. (TSE:MBX) Director Sells 150,000 Shares of Stock

Microbix Biosystems Inc. (TSE:MBX) Director Bo Hollas sold 150,000 shares of Microbix Biosystems stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of C$0.49, for a total value of C$73,500.00.

Microbix Biosystems Trading Down 4.1 %

Shares of TSE:MBX opened at C$0.47 on Friday. The stock’s 50-day simple moving average is C$0.39 and its two-hundred day simple moving average is C$0.36. The stock has a market capitalization of C$64.25 million, a price-to-earnings ratio of 11.75 and a beta of 0.34. Microbix Biosystems Inc. has a 52-week low of C$0.29 and a 52-week high of C$0.52. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.